The Impact of Combined Risk-Reducing Gynecological Surgeries on Outcomes in DIEP Flap and Tissue-Expander Breast Reconstruction

Avinash P. Jayaraman, Travis Boyd, Savannah N. Hampton, Nicholas T. Haddock, Sumeet S. Teotia

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Introduction: In addition to prophylactic mastectomies, BRCA1 and BRCA2 mutation carriers are increasingly choosing to undergo risk-reducing procedures such as hysterectomies and salpingo-oophorectomies. Sometimes these surgeries are performed in the same visit as a mastectomy or a revisionary reconstruction procedure. Literature lacks descriptions of complications and trends for these combined surgeries. Methods: Group 1 patients (n = 10, flaps = 20) had abdominal gynecologic procedures at the time of deep inferior epigastric artery perforator flap (DIEP flap) reconstruction. Group 2 patients (n = 29, breasts = 58) had gynecologic procedures at the time of mastectomy and tissue-expander placement. Group 3 patients (n = 141, breasts = 257) had mastectomy and tissue-expander reconstruction without gynecologic procedures and were used as a control group for group 2. Group 4 patients (n = 357, flaps = 673) had autologous breast reconstruction without gynecologic procedures and were used as a control for group 1. Categorical variables such as complications and flap loss were analyzed using χ2 tests. Continuous variables such as age, body mass index (BMI), operative time, length of stay were analyzed with 2-tailed t tests. Multivariate analyses were run to control for group differences. Results: Groups 1 and 4 were equivalent in age and comorbidities, except group 1 (32.8 kg/m2) had significantly higher BMI than group 4 (31.4 kg/m2), P =.028. Average operating time was statistically equivalent for group 1 patients (610 minutes) and group 4 patients (503 minutes), P =.289. Average hospital stay was equivalent as well (group 1 = 4.4 days, group 4 = 4.1 days, P =.676). Operative times for group 2 patients (457 minutes) were significantly longer than for group 3 patients (288 minutes), P <.01. Group 2 patients (3 nights) had significantly longer hospital stays than group 3 patients (2 nights), P <.01. Group 1 patients (2/20 flaps, 10%) had a significantly higher rate of flap loss than group 4 patients (8/673 flaps, 1%), P <.01. There were no differences in other flap complications. Additionally, there were no significant differences in postoperative tissue-expander complications between group 2 and group 3. Discussion: Both flap losses in Group 1 patients occurred in a single patient with BMI = 39.3 kg/m2 and a personal history of recurrent DVTs. Additionally, the rates of complications across other measures were equivalent between groups. Thus, despite the increased rate of flap loss in Group 1 (10%) vs Group 4 (1.3%), along with the increased operative times and hospital stays, certain patients can be advised that a prophylactic gynecological procedure is safe to combine with breast reconstruction.

Original languageEnglish (US)
Pages (from-to)112-116
Number of pages5
JournalPlastic Surgery
Volume28
Issue number2
DOIs
StatePublished - May 1 2020

Keywords

  • BRCA1
  • BRCA2
  • BSO
  • DIEP flap
  • TAH
  • TAH-BSO
  • breast reconstruction
  • combined gynecological
  • prophylactic
  • tissue expander

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'The Impact of Combined Risk-Reducing Gynecological Surgeries on Outcomes in DIEP Flap and Tissue-Expander Breast Reconstruction'. Together they form a unique fingerprint.

Cite this